Cymbalta (duloxetine) for chronic pain due to osteoarthritis of the knee

Reps will promote Cymbalta (duloxetine) for chronic pain due to osteoarthritis of the knee.

This is a newly approved indication in Canada.

Chronic pain associated with osteoarthritis likely originates from BOTH peripheral and central pain pathways.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote